Orthocell Ltd
ASX:OCC

Watchlist Manager
Orthocell Ltd Logo
Orthocell Ltd
ASX:OCC
Watchlist
Price: 0.64 AUD -3.76% Market Closed
Market Cap: 153m AUD
Have any thoughts about
Orthocell Ltd?
Write Note

Orthocell Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Orthocell Ltd
Operating Expenses Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Orthocell Ltd
ASX:OCC
Operating Expenses
-AU$15.4m
CAGR 3-Years
-9%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Mesoblast Ltd
ASX:MSB
Operating Expenses
-$57.1m
CAGR 3-Years
4%
CAGR 5-Years
8%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Operating Expenses
-$3.9B
CAGR 3-Years
-12%
CAGR 5-Years
-11%
CAGR 10-Years
-12%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Operating Expenses
-AU$39.5m
CAGR 3-Years
-24%
CAGR 5-Years
-22%
CAGR 10-Years
-17%
Telix Pharmaceuticals Ltd
ASX:TLX
Operating Expenses
-AU$296.8m
CAGR 3-Years
-97%
CAGR 5-Years
-76%
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Operating Expenses
-AU$60.4m
CAGR 3-Years
-40%
CAGR 5-Years
-63%
CAGR 10-Years
-28%

See Also

What is Orthocell Ltd's Operating Expenses?
Operating Expenses
-15.4m AUD

Based on the financial report for Jun 30, 2024, Orthocell Ltd's Operating Expenses amounts to -15.4m AUD.

What is Orthocell Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-12%

Over the last year, the Operating Expenses growth was -14%. The average annual Operating Expenses growth rates for Orthocell Ltd have been -9% over the past three years , -12% over the past five years .

Back to Top